Affy Says Q4 Revenue Will Fall 11.5 Percent As It Delays 1M SNP Set Launch Three Months | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Affymetrix this week said it expects fourth-quarter revenue to decline around 11.5 percent as it begins a limited launch of its single-chip SNP 5.0 array but delays by around three months the release of its two-chip, 1 million SNP product.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.